Thank you, yes that luc Montagnier paper I was thinking of, which was an early clue that the virus probably originated in the lab in Wuhan rather than in nature. Lots of little breadcrumbs leading in that direction.
But this isn’t my field, and I’m still confused. I think that we probably agree that the virus escaped from a lab. What I don’t understand is things like “SARS-cov-2 is 72% SIV”. What does that mean? Is it that 72% of the genetic sequences of those two viruses is identical? Or is there a different definition of this? Presumably Montagnier and Perez used the same isolate that was being discussed worldwide at the time, being what was then called the Wuhan-Hu-1 sequence, also published here: https://www.ncbi.nlm.nih.gov/nuccore/1798174254
Moving on to the micro RNA issue, again, this is not my field, but what the abstract states is that “We found that BNT162b2 inhibits SARS-CoV-2 replication through degradation of negative strand viral RNAs that are completely paired with SARS-CoV-2 S-derived miRNAs. Further, CovS-miR-21 derived from BNT162b2 restores circadian rhythm and attenuate immunogenicity.”, which in my limited understanding seems to say that the vaccine interacts with viral micro-rna strands, not that it contains micro RNA. What isn’t clear to me is whether they are saying that the vaccine also codes for micro RNA in addition to the much-discussed spike protein codon.
Only asking because it seems that you have done a deep dive into all of this and because I can’t figure it out on my own.